Waste Management (NYSE:WM) remains one of the most closely watched names in the waste management sector as investors assess its first-quarter performance against key competitors. The company operates one of the largest
More
Born on 2 July 1940 in Nottingham, Kenneth Clarke entered the world just 40 days into Winston Churchill’s wartime premiership, as the Battle of Britain loomed. A bright and quick-witted student, Clarke
More
On June 24, 2026, the Office of Inspector General for the US Department of Health and Human Services published a Request for Information seeking public input on clinical trial participant remuneration. The
More
The Supreme Court’s birthright citizenship ruling produced an unexpected dissent from Justice Neil Gorsuch that carries significant implications for the Trump administration. The Court ruled 6-3 that children born in the United
More
As artificial intelligence reshapes the legal industry, a quiet but fundamental shift is underway in how lawyers create value for the businesses they serve. Writing in Above the Law, lawyer and author
More
Halma PLC (LSE:HLMA) has acquired two healthcare businesses worth a combined £54 million, pushing further into medical technology across Europe. The FTSE 100 safety equipment group purchased Dutch hospital software firm Itemedical
More
Brussels is pushing to narrow its record trade deficit with China by October, but a historic heat wave is complicating that ambition in the most visible way possible. The European Union and
More
CMC Markets (CMCX) was among the standout performers on the FTSE 250 on Thursday, posting sharp gains that caught the attention of investors across the market. The online trading and financial services
More
Brent crude tumbled to $71 per barrel on Thursday morning, hitting its lowest level since late February amid cautious signs of resumed flows through the Strait of Hormuz. The US claimed crude
More
Enanta Pharmaceuticals faced a significant legal setback after the US Court of Appeals for the Federal Circuit affirmed summary judgment invalidating its patent on coronavirus inhibitors. The Federal Circuit ruled the asserted
More